Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Basel Medical (BMGL) over the last 3 years, with Q2 2025 value amounting to $5.3 million.

  • Basel Medical's Accounts Payables rose 17894.01% to $5.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.3 million, marking a year-over-year increase of 17894.01%. This contributed to the annual value of $5.4 million for FY2025, which is 18546.81% up from last year.
  • Latest data reveals that Basel Medical reported Accounts Payables of $5.3 million as of Q2 2025, which was up 17894.01% from $1.5 million recorded in Q4 2024.
  • Basel Medical's Accounts Payables' 5-year high stood at $5.3 million during Q2 2025, with a 5-year trough of -$18671.4 in Q4 2023.
  • For the 3-year period, Basel Medical's Accounts Payables averaged around $2.2 million, with its median value being $1.7 million (2024).
  • As far as peak fluctuations go, Basel Medical's Accounts Payables soared by 813187.77% in 2024, and later surged by 17894.01% in 2025.
  • Over the past 3 years, Basel Medical's Accounts Payables (Quarter) stood at -$18671.4 in 2023, then soared by 8131.88% to $1.5 million in 2024, then skyrocketed by 254.14% to $5.3 million in 2025.
  • Its Accounts Payables stands at $5.3 million for Q2 2025, versus $1.5 million for Q4 2024 and $1.9 million for Q2 2024.